01/31/2023 | Press release | Distributed by Public on 01/31/2023 15:36
Delaware
|
001-01136
|
22-0790350
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S Employer Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.10 Par Value
|
BMY
|
New York Stock Exchange
|
1.000% Notes due 2025
|
BMY25
|
New York Stock Exchange
|
1.750% Notes due 2035
|
BMY35
|
New York Stock Exchange
|
Celgene Contingent Value Rights
|
CELG RT
|
New York Stock Exchange
|
Item 5.02 |
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
|
Item 9.01. |
Financial Statements and Exhibits.
|
(d) |
Exhibits
|
Exhibit
No.
|
Description
|
|
104
|
The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101).
|
Exhibit
No.
|
Description
|
|
104
|
The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101).
|
BRISTOL-MYERS SQUIBB COMPANY
|
|||
Dated: January 31, 2023
|
By:
|
/s/ Kimberly M. Jablonski
|
|
Name:
|
Kimberly M. Jablonski
|
||
Title:
|
Corporate Secretary
|